Blood coagulation factor XIII for treating platelet disorders

Details Blood coagulation factor XIII for treating platelet disorders Blood coagulation factor XIII for treating platelet disorders

2006-03-07

2006-03-07

Carlson, Karen Cochrane (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07008926

ABSTRACT:
Use of factor XIII for treating the symptoms of thrombocytopenia. A patient having thrombocytopenia, either chemically- or metabolically induced, is treated by administering factor XIII.

REFERENCES:
patent: 5612456 (1997-03-01), Bishop et al.
patent: WO 93/12813 (1993-07-01), None
Anwar et al., Delayed Umbilical Bleeding-A Presenting Feature for Factor XIII Deficiency: Clinical Features, Genetics, and Managment, Oediatrics, (2002), 2 Fe., 109(2), p. 1-7.

Affiliated with

Also associated with

Rating

Blood coagulation factor XIII for treating platelet disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blood coagulation factor XIII for treating platelet disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood coagulation factor XIII for treating platelet disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3551483